Vasoactive therapy in shock.
作者信息
Jha A, Zilahi G, Rhodes A
机构信息
Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
St George's University Hospitals NHS Foundation Trust, London, UK.
出版信息
BJA Educ. 2021 Jul;21(7):270-277. doi: 10.1016/j.bjae.2021.03.002. Epub 2021 Apr 28.
Abstract
摘要
相似文献
1
Vasoactive therapy in shock.休克中的血管活性药物治疗。
BJA Educ. 2021 Jul;21(7):270-277. doi: 10.1016/j.bjae.2021.03.002. Epub 2021 Apr 28.
2
A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.一项比较特利加压素与去甲肾上腺素用于肝硬化合并感染性休克患者的随机试验。
Liver Int. 2017 Apr;37(4):552-561. doi: 10.1111/liv.13252. Epub 2016 Oct 20.
3
Dopamine versus noradrenaline in septic shock.多巴胺与去甲肾上腺素治疗感染性休克的比较。
Australas Med J. 2011;4(10):571-4. doi: 10.4066/AMJ.2011.761. Epub 2011 Oct 31.
4
Clinical Signs to Categorize Shock and Target Vasoactive Medications in Warm Versus Cold Pediatric Septic Shock.临床征象对暖休克与冷休克儿童脓毒性休克进行分类及靶向血管活性药物治疗。
Pediatr Crit Care Med. 2020 Dec;21(12):1051-1058. doi: 10.1097/PCC.0000000000002481.
5
Vasoactive Agents for Adult Septic Shock: An Update and Review.血管活性药物在成人脓毒性休克中的应用：更新与评价。
J Pharm Pract. 2020 Aug;33(4):523-532. doi: 10.1177/0897190019844124. Epub 2019 May 5.
6
Bundle Adherence of Intravenous Antibiotic Fluid Resuscitation and Vasopressor in Children with Severe Sepsis or Septic Shock.重症脓毒症或脓毒性休克患儿静脉抗生素液体复苏与血管活性药物的捆绑式依从性
Indian J Crit Care Med. 2020 Feb;24(2):128-132. doi: 10.5005/jp-journals-10071-23336.
7
The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.右美托咪定对感染性休克患者血管加压素需求的影响：镇静实践在重症监护评估 [SPICE III] 试验的亚组分析。
Crit Care. 2020 Jul 16;24(1):441. doi: 10.1186/s13054-020-03115-x.
8
Noradrenaline use is not associated with extubation failure in septic patients.去甲肾上腺素的使用与脓毒症患者拔管失败无关。
Anaesth Intensive Care. 2008 May;36(3):385-90. doi: 10.1177/0310057X0803600310.
9
Evaluation of a novel 5-group classification system of sepsis by vasopressor use and initial serum lactate in the emergency department.评估在急诊科使用血管加压药和初始血清乳酸的新型 5 分组脓毒症分类系统。
Intern Emerg Med. 2018 Mar;13(2):257-268. doi: 10.1007/s11739-017-1607-y. Epub 2017 Jan 28.
10
Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.血管活性药物治疗的广泛变异性：中国重症监护病房的全国性调查。
Chin Med J (Engl). 2015 Apr 20;128(8):1014-20. doi: 10.4103/0366-6999.155064.
引用本文的文献
1
The Omics Complexity in Sepsis: The Limits of the Personalized Medicine Approach.脓毒症中的组学复杂性：个性化医疗方法的局限性
J Pers Med. 2024 Feb 20;14(3):225. doi: 10.3390/jpm14030225.
2
Management of the acute on chronic liver failure in the intensive care unit.重症监护病房中慢性肝功能衰竭急性发作的管理。
Liver Int. 2025 Mar;45(3):e15659. doi: 10.1111/liv.15659. Epub 2023 Jun 27.
3
Non-Invasive Dynamic Reperfusion of Microvessels Controlled by Optical Tweezers.光镊控制的微血管无创动态再灌注
Front Bioeng Biotechnol. 2022 Jul 14;10:952537. doi: 10.3389/fbioe.2022.952537. eCollection 2022.
本文引用的文献
1
Dynamic Arterial Elastance as a Ventriculo-Arterial Coupling Index: An Experimental Animal Study.动态动脉弹性作为心室-动脉耦合指数：一项实验动物研究。
Front Physiol. 2020 Apr 6;11:284. doi: 10.3389/fphys.2020.00284. eCollection 2020.
2
Vasopressin and its analogues in shock states: a review.血管加压素及其类似物在休克状态中的应用综述
Ann Intensive Care. 2020 Jan 22;10(1):9. doi: 10.1186/s13613-020-0628-2.
3
Vasopressor therapy in critically ill patients with shock.血管加压素治疗休克危重症患者。
Intensive Care Med. 2019 Nov;45(11):1503-1517. doi: 10.1007/s00134-019-05801-z. Epub 2019 Oct 23.
4
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).2019年欧洲心脏病学会（ESC）与欧洲呼吸学会（ERS）合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
5
Inotropes and vasopressors use in cardiogenic shock: when, which and how much?正性肌力药和血管加压药在心源性休克中的应用：何时用、用哪种、用多少？
Curr Opin Crit Care. 2019 Aug;25(4):384-390. doi: 10.1097/MCC.0000000000000632.
6
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.美国心脏病学会（ACC）、美国心脏协会（AHA）、重症医学会（SCCM）和胸外科医师学会（STS）于 2019 年 4 月共同发布了心血管造影协会（SCAI）关于心源性休克分类的临床专家共识声明。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37. doi: 10.1002/ccd.28329. Epub 2019 May 19.
7
Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.脓毒性休克中的血管加压素：随机对照试验的个体患者数据荟萃分析。
Intensive Care Med. 2019 Jun;45(6):844-855. doi: 10.1007/s00134-019-05620-2. Epub 2019 May 6.
8
Broad spectrum vasopressors: a new approach to the initial management of septic shock?广谱血管加压素类药物：脓毒性休克初始治疗的新方法？
Crit Care. 2019 Apr 16;23(1):124. doi: 10.1186/s13054-019-2420-y.
9
Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.去甲肾上腺素和血管加压素与去甲肾上腺素和肾上腺素治疗脓毒性休克成人患者的比较。
Ann Pharmacother. 2019 Sep;53(9):877-885. doi: 10.1177/1060028019843664. Epub 2019 Apr 8.
10
Refractory septic shock: our pragmatic approach.难治性感染性休克：我们的实用方法。
Crit Care. 2018 Sep 19;22(1):215. doi: 10.1186/s13054-018-2144-4.
Zotero 插件